Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?

MLA

Ovsepian, Saak Victor, and Valerie Bríd O’Leary. “Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?” Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 15, no. 4, Oct. 2018, pp. 1032–35. EBSCOhost, https://doi.org/10.1007/s13311-018-0668-6.

APA

Ovsepian, S. V., & O’Leary, V. B. (2018). Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease? Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, 15(4), 1032–1035. https://doi.org/10.1007/s13311-018-0668-6

Chicago

Ovsepian, Saak Victor, and Valerie Bríd O’Leary. 2018. “Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?” Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 15 (4): 1032–35. doi:10.1007/s13311-018-0668-6.